Evidence mapPaperPMID 40978749Full record

ArticleFrontiers in medicine2025

Global, regional, and national burden of cataract among older adults from 1990 to 2021: a comprehensive analysis based on the global burden of disease study 2021.

Zhongqi Wan, Jianhao Bai, Weifang Wang, Qing Peng

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhongqi Wan *Department of Ophthalmology, Shanghai Tenth People's Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
Jianhao Bai *Department of Ophthalmology, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
Weifang WangDepartment of Ophthalmology, Shanghai Eighth People's Hospital, Shanghai, China.
Qing PengDepartment of Ophthalmology, Shanghai Tenth People's Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the global, regional, and national burden of cataract among individuals aged 60 years and older from 1990 to 2021, and to examine disparities by age, sex, socio-demographic level, and geographic region using data from the Global Burden of Disease Study (GBD) 2021. Methods: We extracted cataract prevalence data for 204 countries from GBD 2021 and analyzed age-standardized prevalence rates (ASPRs) across regions and Socio-demographic Index (SDI) levels. Sex- and age-specific patterns were assessed. Age-period-cohort modeling, decomposition analysis, absolute and relative inequality metrics, and frontier analysis were applied to assess temporal trends, demographic drivers, and disparities. Results: In 2021, the global ASPR of cataract among the elderly was 7,748.5 per 100,000, with significantly higher rates in South Asia. Females had consistently higher ASPRs than males across all age groups and regions. Prevalence increased with age, peaking in those aged ≥95 years. Age-period-cohort (APC) analysis revealed that aging is the dominant driver of burden, with minor period and cohort effects. Decomposition showed that global prevalence increases were largely driven by population growth (87.4%), with smaller contributions from aging and epidemiological change. Substantial inequality persisted: low-SDI countries bore disproportionately higher burdens, with minimal improvement from 1990 to 2021. Frontier analysis revealed large performance gaps even among similarly developed countries. Conclusion: Cataract remains a major and unequal public health burden among older adults, particularly in low- and middle-SDI settings. Addressing service delivery inefficiencies, expanding surgical coverage, and implementing equitable aging-focused eye care policies are essential to reduce avoidable visual impairment globally.

Indexed as

age-standardized prevalencecataractglobal burden of diseasehealth inequalityolder adults

Identifiers

PMID40978749
PMCPMC12443760

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.